Cleared Traditional

K213872 - ComPAS2

K213872 is an FDA 510(k) clearance for ComPAS2, manufactured by Morgan Scientific, Inc.. The device is a Class 2 Anesthesiology device with product code BZG cleared through the Traditional 510(k) pathway after a 214-day FDA review.

K213872 · Morgan Scientific, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2022
Decision
214d
Days
Class 2
Risk

K213872 is an FDA 510(k) clearance for the ComPAS2. Classified as Spirometer, Diagnostic (product code BZG), Class II - Special Controls.

Submitted by Morgan Scientific, Inc. (Haverhill, US). The FDA issued a Cleared decision on July 15, 2022 after a review of 214 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1840 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Morgan Scientific, Inc. devices

FDA 510(k) Submission Details - K213872

510(k) Number K213872 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 13, 2021
Decision Date July 15, 2022
Days to Decision 214 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
74d slower than avg
Panel avg: 140d · This submission: 214d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

BZG Device Classification - Class 2, Special Controls

Product Code BZG Spirometer, Diagnostic
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1840
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - BZG Spirometer, Diagnostic

All 50
Devices cleared under the same product code (BZG) and FDA review panel - the closest regulatory comparables to K213872.
Alveoair Digital Spirometer
K222525 · Roundworks Technologies Private Limited · Aug 2023
Air Smart Extra Spirometer
K222443 · Feellife Health, Inc. · Aug 2023
SpiroHome Personal, SpiroHome Clinic
K213754 · Inofab Saglik Teknolojileri A.S · Jun 2023
Vitalograph Model 6000 Alpha
K212938 · Vitalograph (Ireland) , Ltd. · Jan 2022
Spirometer
K201493 · Mehow Innovative, Ltd. · Jun 2021
GoSpiro
K202837 · Monitored Therapeutics, Inc. · Dec 2020